Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.37 USD | -0.88% | -7.13% | +31.46% |
09/02 | Oppenheimer Adjusts Enanta Pharmaceuticals Price Target to $17 From $21, Maintains Perform Rating | MT |
07/02 | Transcript : Enanta Pharmaceuticals, Inc., Q1 2024 Earnings Call, Feb 07, 2024 |
- Stock Market
- Equities
- ENTA Stock
- News Enanta Pharmaceuticals, Inc.